ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 68 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $772 | +243.1% | 605,700 | -12.2% | 0.00% | – |
| Q2 2023 | $225 | -8.2% | 689,713 | +21.1% | 0.00% | – |
| Q1 2023 | $245 | -44.9% | 569,700 | -32.2% | 0.00% | -100.0% |
| Q4 2022 | $445 | -99.9% | 840,500 | -24.3% | 0.00% | 0.0% |
| Q3 2022 | $813,000 | -3.2% | 1,110,035 | +50.7% | 0.00% | 0.0% |
| Q2 2022 | $840,000 | +24.8% | 736,600 | +124.3% | 0.00% | 0.0% |
| Q1 2022 | $673,000 | -39.9% | 328,400 | -15.4% | 0.00% | 0.0% |
| Q4 2021 | $1,119,000 | -26.1% | 388,385 | +8.8% | 0.00% | -50.0% |
| Q3 2021 | $1,514,000 | +218.7% | 356,982 | +147.9% | 0.00% | +100.0% |
| Q4 2020 | $475,000 | +666.1% | 144,000 | +674.2% | 0.00% | – |
| Q3 2020 | $62,000 | -88.7% | 18,600 | -89.9% | 0.00% | -100.0% |
| Q4 2018 | $547,000 | – | 184,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
| Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
| Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
| Founders Capital Management | 3,000 | $9,000 | 0.01% |
| King Wealth Management Group | 16,000 | $33,000 | 0.01% |
| Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |